These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 15039383)
1. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383 [TBL] [Abstract][Full Text] [Related]
2. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096 [TBL] [Abstract][Full Text] [Related]
3. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800 [TBL] [Abstract][Full Text] [Related]
4. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724 [TBL] [Abstract][Full Text] [Related]
5. Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1. Okumura G; Abe F; Hirochika R; Shibuya A; Shibuya K Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):135-139. PubMed ID: 28498033 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells. Seth S; Georgoudaki AM; Chambers BJ; Qiu Q; Kremmer E; Maier MK; Czeloth N; Ravens I; Foerster R; Bernhardt G J Leukoc Biol; 2009 Jul; 86(1):91-101. PubMed ID: 19380711 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766 [TBL] [Abstract][Full Text] [Related]
9. Identification of CD112R as a novel checkpoint for human T cells. Zhu Y; Paniccia A; Schulick AC; Chen W; Koenig MR; Byers JT; Yao S; Bevers S; Edil BH J Exp Med; 2016 Feb; 213(2):167-76. PubMed ID: 26755705 [TBL] [Abstract][Full Text] [Related]
10. The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation. Kraus AK; Chen J; Edenhofer I; Ravens I; Gaspert A; Cippà PE; Mueller S; Wuthrich RP; Segerer S; Bernhardt G; Fehr T PLoS One; 2016; 11(2):e0147951. PubMed ID: 26840537 [TBL] [Abstract][Full Text] [Related]
11. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Chan CJ; Martinet L; Gilfillan S; Souza-Fonseca-Guimaraes F; Chow MT; Town L; Ritchie DS; Colonna M; Andrews DM; Smyth MJ Nat Immunol; 2014 May; 15(5):431-8. PubMed ID: 24658051 [TBL] [Abstract][Full Text] [Related]
12. TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT. Nakamura Y; Naito K; Yamashita-Kanemaru Y; Komori D; Hirochika R; Shibuya A; Shibuya K Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):105-109. PubMed ID: 29648914 [TBL] [Abstract][Full Text] [Related]
14. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681 [TBL] [Abstract][Full Text] [Related]
15. Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5. Wang H; Qi J; Zhang S; Li Y; Tan S; Gao GF Proc Natl Acad Sci U S A; 2019 Jan; 116(3):988-996. PubMed ID: 30591568 [TBL] [Abstract][Full Text] [Related]
16. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D. Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD Front Immunol; 2020; 11():40. PubMed ID: 32082316 [TBL] [Abstract][Full Text] [Related]
17. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979 [TBL] [Abstract][Full Text] [Related]